2. GPCR/G Protein
  3. Platelet-activating Factor Receptor (PAFR)
  4. Homoeriodictyol 7-O-β-D-glucoside

Homoeriodictyol 7-O-β-D-glucoside is a natural platelet-activating factor (PAF) antagonist. Homoeriodictyol 7-O-β-D-glucoside inhibits human and rabbit platelet aggregation induced by PAF, with an IC50 of 0.8 μM.

For research use only. We do not sell to patients.

Homoeriodictyol 7-O-β-D-glucoside Chemical Structure

Homoeriodictyol 7-O-β-D-glucoside Chemical Structure

CAS No. : 14982-11-7

Size Price Stock Quantity
1 mg USD 290 Get quote 3 - 4 weeks 2 - 3 weeks 2 - 3 weeks
5 mg USD 740 Get quote 3 - 4 weeks 2 - 3 weeks 2 - 3 weeks
10 mg Get quote
25 mg Get quote

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Homoeriodictyol 7-O-β-D-glucoside Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Homoeriodictyol 7-O-β-D-glucoside is a natural platelet-activating factor (PAF) antagonist. Homoeriodictyol 7-O-β-D-glucoside inhibits human and rabbit platelet aggregation induced by PAF, with an IC50 of 0.8 μM[1].

IC50 & Target

platelet-activating factor[1]
In Vitro

Homoeriodictyol 7-O-β-D-glucoside significantly inhibits human and rabbit platelet aggregation induced by PAF, but has no inhibitory effect on platelet aggregation induced by Adenosine diphosphate (ADP)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Homoeriodictyol 7-O-β-D-glucoside Related Antibodies
Molecular Weight

464.42

Formula

C22H24O11
CAS No.
SMILES

O=C1C2=C(O)C=C(O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)CO)C=C2O[C@H](C4=CC(OC)=C(C=C4)O)C1
Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Homoeriodictyol 7-O-β-D-glucoside Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Homoeriodictyol 7-O-β-D-glucoside14982-11-7Platelet-activating Factor Receptor (PAFR)plateletactivatingfactorPAFaggregationInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Homoeriodictyol 7-O-β-D-glucoside
Cat. No.:
HY-N8218
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.